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Multidrug resistance (MDR) represents one of the major
setbacks to chemotherapy and can occur due to the
overexpression of efflux pumps as P-glycoprotein (Pgp),
multiple resistance-related protein 1 (MRP1) and lung
resistance-related protein (LRP). Verapamil, a substrate
for Pgp, modulates its activity. L-buthionine-sulfoximine
(BSO) can be used as blocker for MRP1. In this study
we aim to compare transport kinetics for sensitive and
resistant human colorectal adenocarcinoma cell lines, in
the presence and absence of verapamil and BSO,
through
99mTc-Sestamibi.
Pgp, MRP1 and LRP expression was evaluated in resis-
tant (LS1034) and sensitive (WiDr) human colorectal
adenocarcinoma cell lines using flow-cytometry. Wes-
tern blot was also used to analyze Pgp expression. Cellu-
lar transport kinetics was assessed in the presence and
absence of verapamil and BSO. Retention studies were
performed after cell incubation with those drugs, for dif-
ferent time intervals (10 and 60 minutes) and concentra-
tions (10, 25, 50 and 100 µM), using
99mTc-Sestamibi.
Pgp expression was significantly higher (p < 0.05) in
resistant cells, although LRP was also expressed.
Western blotting analysis confirmed flow-cytometry
results.
99mTc-Sestamibi retention percentage was signif-
icantly higher (p < 0.05) in the resistant cell line for all
time-points considered. In resistant cells incubated with
MDR modulators there were statistically significant dif-
ferences (p < 0.05) among the modulators used but only
for the first minutes after incubation with the
radiotracer.
The data obtained suggest that these modulators
should be used immediately before the cytotoxic drugs
are administrated.
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